Ellis C Becking

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Skeletal Muscle

Dna Methylation

Top Venues

Prenatal diagnosis

Clinical chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ellis C Becking, Lidewij Henneman, Neeltje M T H Crombag, Janneke Bertorotta, Ylana Rijsbergen, Caroline J Bax, Elsbeth van Vliet-Lachotzki, Peter G Scheffer, Mirielle N Bekker
Perspectives of pregnant women on broadening the scope of noninvasive prenatal testing from screening for foetal aneuploidies to prediction of adverse pregnancy outcomes: A qualitative study. Prenatal diagnosis (2024)
Ellis C Becking, Lidewij Henneman, Neeltje M T H Crombag, Janneke Bertorotta, Ylana Rijsbergen, Caroline J Bax, Elsbeth van Vliet-Lachotzki, Peter G Scheffer, Mirielle N Bekker
Perspectives of pregnant women on broadening the scope of noninvasive prenatal testing from screening for foetal aneuploidies to prediction of adverse pregnancy outcomes: A qualitative study. Prenatal diagnosis 44 (9) (2024)
Ellis C Becking, Lidewij Henneman, Neeltje M T H Crombag, Janneke Bertorotta, Ylana Rijsbergen, Caroline J Bax, Elsbeth van Vliet-Lachotzki, Peter G Scheffer, Mirielle N Bekker
Perspectives of pregnant women on broadening the scope of noninvasive prenatal testing from screening for foetal aneuploidies to prediction of adverse pregnancy outcomes: A qualitative study. Prenatal diagnosis 44 (9) (2024)
Ellis C Becking, Lidewij Henneman, Neeltje M T H Crombag, Janneke Bertorotta, Ylana Rijsbergen, Caroline J Bax, Elsbeth van Vliet-Lachotzki, Peter G Scheffer, Mirielle N Bekker
Perspectives of pregnant women on broadening the scope of noninvasive prenatal testing from screening for foetal aneuploidies to prediction of adverse pregnancy outcomes: A qualitative study. Prenatal diagnosis 44 (9) (2024)
Ellis C Becking, Ewoud Schuit, Sophie M E van Baar de Knegt, Erik A Sistermans, Lidewij Henneman, Mireille N Bekker, Peter G Scheffer
Association between low fetal fraction in cell-free DNA screening and fetal chromosomal aberrations: A systematic review and meta-analysis. Prenatal diagnosis (2023)
Ellis C Becking, Jasper Linthorst, Simon Patton, Weronika Gutowska-Ding, Rebecca Goodall, Farrah Khawaja, Fiona Morgan, Zandra Deans, Lyn S Chitty, Mireille N Bekker, Peter G Scheffer, Erik A Sistermans
Variability in Fetal Fraction Estimation: Comparing Fetal Fractions Reported by Noninvasive Prenatal Testing Providers Globally. Clinical chemistry 69 (2) (2023)
Ellis C Becking, Jasper Linthorst, Simon Patton, Weronika Gutowska-Ding, Rebecca Goodall, Farrah Khawaja, Fiona Morgan, Zandra Deans, Lyn S Chitty, Mireille N Bekker, Peter G Scheffer, Erik A Sistermans
Variability in Fetal Fraction Estimation: Comparing Fetal Fractions Reported by Noninvasive Prenatal Testing Providers Globally. Clinical chemistry 69 (2) (2023)
Ellis C Becking, Ewoud Schuit, Sophie M E van Baar de Knegt, Erik A Sistermans, Lidewij Henneman, Mireille N Bekker, Peter G Scheffer
Association between low fetal fraction in cell-free DNA screening and fetal chromosomal aberrations: A systematic review and meta-analysis. Prenatal diagnosis (2023)
Ellis C Becking, Jasper Linthorst, Simon Patton, Weronika Gutowska-Ding, Rebecca Goodall, Farrah Khawaja, Fiona Morgan, Zandra Deans, Lyn S Chitty, Mireille N Bekker, Peter G Scheffer, Erik A Sistermans
Variability in Fetal Fraction Estimation: Comparing Fetal Fractions Reported by Noninvasive Prenatal Testing Providers Globally. Clinical chemistry (2022)
Peter G Scheffer, Soetinah A M Wirjosoekarto, Ellis C Becking, Marjan M Weiss, Caroline J Bax, Dick Oepkes, Erik A Sistermans, Lidewij Henneman, Mirielle N Bekker
Association between low fetal fraction in cell-free DNA testing and adverse pregnancy outcome: A systematic review. Prenatal diagnosis 41 (10) (2021)
Ellis C Becking, Soetinah A M Wirjosoekarto, Peter G Scheffer, Julia V M Huiskes, Marinka J Remmelink, Erik A Sistermans, Caroline J Bax, Janneke M Weiss, Lidewij Henneman, Mirielle N Bekker
Low fetal fraction in cell-free DNA testing is associated with adverse pregnancy outcome: Analysis of a subcohort of the TRIDENT-2 study. Prenatal diagnosis 41 (10) (2021)